Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mira Keyes

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2009
Sequence variant discovery in DNA repair genes from radiosensitive and radiotolerant prostate brachytherapy patientsTrevor J Pugh, Mira Keyes, Lorena Barclay, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2020
A biochemical definition of cure after brachytherapy for prostate cancerJuanita M Crook, Chad Tang, Howard Thames, et al.
Brachytherapy|November 2, 2020
The American Brachytherapy Society prostate brachytherapy LDR/HDR simulation workshops: Hands-on, step-by-step training in the process of quality assuranceSteven J Frank, Firas Mourtada, Juanita Crook, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2008
Evaluation of dosimetric parameters and disease response after 125 iodine transperineal brachytherapy for low- and intermediate-risk prostate cancerW James Morris, Mira Keyes, David Palma, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 8, 2023
Outcomes after PD-103 versus I-125 for low dose rate prostate brachytherapy monotherapy: An international, multi-institutional studyChad Tang, Jeremiah Sanders, Howard Thames, et al.
International Journal of Radiation Oncology, Biology, Physics|August 25, 2014
Establishing high-quality prostate brachytherapy using a phantom simulator training programNikhil G Thaker, Rajat J Kudchadker, David A Swanson, et al.
Brachytherapy|September 12, 2021
Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statementMartin T King, Mira Keyes, Steven J Frank, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2018
The American Brachytherapy Society and the American Radium Society Appropriate Use Criteria Genitourinary Committee Endorse the American Society of Clinical Oncology/Cancer Care Ontario GuidelinesAlbert J Chang, Sean McBride, Mira Keyes, et al.
BJU International|January 14, 2012
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupPeter Grimm, Ignace Billiet, David Bostwick, et al.
Brachytherapy|July 3, 2025
Joint ABS/GEC-ESTRO Consensus Statement on the objectives of training in brachytherapy for physiciansMira Keyes, Alina Emiliana Sturdza, Juanita Crook, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2009
Sequence variant discovery in DNA repair genes from radiosensitive and radiotolerant prostate brachytherapy patientsTrevor J Pugh, Mira Keyes, Lorena Barclay, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2020
A biochemical definition of cure after brachytherapy for prostate cancerJuanita M Crook, Chad Tang, Howard Thames, et al.
Brachytherapy|November 2, 2020
The American Brachytherapy Society prostate brachytherapy LDR/HDR simulation workshops: Hands-on, step-by-step training in the process of quality assuranceSteven J Frank, Firas Mourtada, Juanita Crook, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2008
Evaluation of dosimetric parameters and disease response after 125 iodine transperineal brachytherapy for low- and intermediate-risk prostate cancerW James Morris, Mira Keyes, David Palma, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 8, 2023
Outcomes after PD-103 versus I-125 for low dose rate prostate brachytherapy monotherapy: An international, multi-institutional studyChad Tang, Jeremiah Sanders, Howard Thames, et al.
International Journal of Radiation Oncology, Biology, Physics|August 25, 2014
Establishing high-quality prostate brachytherapy using a phantom simulator training programNikhil G Thaker, Rajat J Kudchadker, David A Swanson, et al.
Brachytherapy|September 12, 2021
Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statementMartin T King, Mira Keyes, Steven J Frank, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2018
The American Brachytherapy Society and the American Radium Society Appropriate Use Criteria Genitourinary Committee Endorse the American Society of Clinical Oncology/Cancer Care Ontario GuidelinesAlbert J Chang, Sean McBride, Mira Keyes, et al.
BJU International|January 14, 2012
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupPeter Grimm, Ignace Billiet, David Bostwick, et al.
Brachytherapy|July 3, 2025
Joint ABS/GEC-ESTRO Consensus Statement on the objectives of training in brachytherapy for physiciansMira Keyes, Alina Emiliana Sturdza, Juanita Crook, et al.
Pageof 10